Literature DB >> 17072326

Nuclear factor-kappa B pathways in Drosophila.

S Minakhina1, R Steward.   

Abstract

The nuclear factor kappa B (NF-kappaB) pathways in Drosophila are multi-component pathways, as in vertebrates, that regulate the expression of many genes responsible for the formation of dorsal-ventral polarity in the early embryo, the innate immune response to infection with Gram- negative and positive bacteria and fungi, the cellular immune response and hematopoiesis. Overactivation of the fly pathway can result in developmental defects, overproliferation of hemocytes and the formation of melanotic tumors or nodules. The extracellular events leading to the maturation of the ligand for initiation of the Drosophila NF-kappaB pathway is not conserved between flies and vertebrates, but the Toll receptor and downstream events are remarkably similar. NF-kappaB proteins have been identified in mollusks, and arthropods such as horseshoe crabs and beetles, indicating that this pathway has been established more than 500 million years ago. The fly NF-kappaB pathways are less complex than those in vertebrates, with the involvement of fewer proteins, but they are, nonetheless, just as important as their vertebrate counterparts for the life of the fly.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072326     DOI: 10.1038/sj.onc.1209940

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  24 in total

Review 1.  NF-kappaB in the immune response of Drosophila.

Authors:  Charles Hetru; Jules A Hoffmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

2.  Heterodimers of NF-kappaB transcription factors DIF and Relish regulate antimicrobial peptide genes in Drosophila.

Authors:  Takahiro Tanji; Eun-Young Yun; Y Tony Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Dynamic repositioning of dorsal to two different kappaB motifs controls its autoregulation during immune response in Drosophila.

Authors:  Nirotpal Mrinal; Javaregowda Nagaraju
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

4.  Characterization of the core elements of the NF-κB signaling pathway of the sea anemone Nematostella vectensis.

Authors:  Francis S Wolenski; Michael R Garbati; Tristan J Lubinski; Nikki Traylor-Knowles; Erica Dresselhaus; Derek J Stefanik; Haley Goucher; John R Finnerty; Thomas D Gilmore
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

5.  Functional analysis of Toll-related genes in Drosophila.

Authors:  Yoshimasa Yagi; Yasuyoshi Nishida; Y Tony Ip
Journal:  Dev Growth Differ       Date:  2010-12       Impact factor: 2.053

Review 6.  NF-κB/Rel proteins and the humoral immune responses of Drosophila melanogaster.

Authors:  Sandhya Ganesan; Kamna Aggarwal; Nicholas Paquette; Neal Silverman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

7.  Sleep triggered by an immune response in Drosophila is regulated by the circadian clock and requires the NFkappaB Relish.

Authors:  Tzu-Hsing Kuo; Douglas H Pike; Zahra Beizaeipour; Julie A Williams
Journal:  BMC Neurosci       Date:  2010-02-09       Impact factor: 3.288

8.  Dorsal interacting protein 3 potentiates activation by Drosophila Rel homology domain proteins.

Authors:  Girish S Ratnaparkhi; Hao A Duong; Albert J Courey
Journal:  Dev Comp Immunol       Date:  2008-05-16       Impact factor: 3.636

Review 9.  Dynamics of maternal morphogen gradients in Drosophila.

Authors:  Stanislav Y Shvartsman; Mathieu Coppey; Alexander M Berezhkovskii
Journal:  Curr Opin Genet Dev       Date:  2008-07-21       Impact factor: 5.578

10.  Two roles for the Drosophila IKK complex in the activation of Relish and the induction of antimicrobial peptide genes.

Authors:  Deniz Ertürk-Hasdemir; Meike Broemer; François Leulier; William S Lane; Nicholas Paquette; Daye Hwang; Chan-Hee Kim; Svenja Stöven; Pascal Meier; Neal Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.